Riskpilot← Back to searchSign inGet full accessSMEIL ApS
APSActiveCVR 40324976Tesch Alle 14Other education n.e.c. · NACE 8559Est. 2019— employees
Revenue 2025
DKK 55K
-738% vs 2024
EBITDA margin
100.0%
+738% vs 2024
Equity ratio
67.6%
Financial strength
Net profit 2025
DKK 55K
+734% vs 2024
| Revenue | DKK 55K | -738% |
| EBITDA | DKK 55K | +738% |
| Net profit | DKK 55K | +734% |
| Total assets | DKK 137K | +77% |
| Equity | DKK 93K | +143% |
| Employees | — | — |
Legal name
SMEIL ApS
CVR number
40324976
Legal form
Anpartsselskab
NACE code
8559 · Other education n.e.c.
Founded
1. marts 2019
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er udbud af undervisning, efteruddannelse og konsulentarbejde indenfor det medicinske sundhedsområde, handel med fast ejendom og værdipapirer samt eventuel anden erhvervsmæssig aktivitet i tilknytning hertil
Address
Tesch Alle 14
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 2 | 149 | 27 | -118 | -9 | 55 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 2 | 149 | 27 | -118 | -9 | 55 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 2 | 149 | 27 | -118 | -9 | 55 |
| Net financials | -2 | -2 | -4 | -2 | -0 | 0 |
| Profit before tax | 0 | 147 | 23 | -120 | -9 | 55 |
| Tax | 2 | 33 | 9 | -0 | -0 | -0 |
| Net profit | -2 | 115 | 14 | -120 | -9 | 55 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 65 | 209 | 259 | 96 | 78 | 137 |
| Equity | 38 | 152 | 167 | 47 | 38 | 93 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 28 | 57 | 92 | 50 | 40 | 45 |
| Total debt | 28 | 57 | 92 | 50 | 40 | 45 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20202025
Equity ratio
67.6%
This company
38.2%
Market median
+77% vs market
20202025
Return on equity
58.9%
This company
18.4%
Market median
+220% vs market
20202025
Net profit margin
100.2%
This company
8.1%
Market median
+1137% vs market
20202025
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20202025
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
20202025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-03-01 – 2020-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JH Management | Management | 2019 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SMEIL ApS 
Det Personlige Lægeteam ApSBoard members of SMEIL ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johnny Hast Hansen | Management | 0 companies |